DK0500108T3 - Forbedret aktivering af rekombinante proteiner - Google Patents
Forbedret aktivering af rekombinante proteinerInfo
- Publication number
- DK0500108T3 DK0500108T3 DK92102864.3T DK92102864T DK0500108T3 DK 0500108 T3 DK0500108 T3 DK 0500108T3 DK 92102864 T DK92102864 T DK 92102864T DK 0500108 T3 DK0500108 T3 DK 0500108T3
- Authority
- DK
- Denmark
- Prior art keywords
- recombinant proteins
- enhanced activation
- amino acids
- helper sequences
- relative hydrophobicities
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/08—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Adhesive Tapes (AREA)
- Dental Preparations (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4105480A DE4105480A1 (de) | 1991-02-21 | 1991-02-21 | Verbesserte aktivierung von rekombinanten proteinen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0500108T3 true DK0500108T3 (da) | 1997-03-24 |
Family
ID=6425597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92102864.3T DK0500108T3 (da) | 1991-02-21 | 1992-02-20 | Forbedret aktivering af rekombinante proteiner |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5578710A (no) |
| EP (1) | EP0500108B1 (no) |
| JP (1) | JP2528232B2 (no) |
| KR (1) | KR950014493B1 (no) |
| AT (1) | ATE144284T1 (no) |
| AU (1) | AU641081B2 (no) |
| CA (1) | CA2061569C (no) |
| CZ (1) | CZ282744B6 (no) |
| DE (2) | DE4105480A1 (no) |
| DK (1) | DK0500108T3 (no) |
| ES (1) | ES2093122T3 (no) |
| FI (1) | FI106029B (no) |
| GR (1) | GR3021395T3 (no) |
| HU (1) | HU214881B (no) |
| IE (1) | IE920276A1 (no) |
| IL (1) | IL101024A (no) |
| MX (1) | MX9200709A (no) |
| NO (1) | NO300329B1 (no) |
| NZ (1) | NZ241570A (no) |
| ZA (1) | ZA921230B (no) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5718893A (en) * | 1984-04-15 | 1998-02-17 | Foster; Preston F. | Use of G-CSF to reduce acute rejection |
| US5581476A (en) | 1993-01-28 | 1996-12-03 | Amgen Inc. | Computer-based methods and articles of manufacture for preparing G-CSF analogs |
| SE9301057L (sv) * | 1993-03-30 | 1994-10-01 | Pharmacia Ab | Beredning med kontrollerad frisättning |
| US5536495A (en) * | 1994-04-15 | 1996-07-16 | Foster; Preston F. | Use of G-CSF to reduce acute rejection |
| US20030053982A1 (en) | 1994-09-26 | 2003-03-20 | Kinstler Olaf B. | N-terminally chemically modified protein compositions and methods |
| US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
| US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
| AU9096001A (en) | 2000-09-08 | 2002-03-22 | Amgen Inc | G-csf analog compositions and methods |
| ES2309167T3 (es) | 2001-02-19 | 2008-12-16 | Merck Patent Gmbh | Metodo para identificar epitotes de celulas t y metodo para preparar moleculas con inmunogenicidad reducida. |
| DE60236522D1 (de) | 2001-07-11 | 2010-07-08 | Maxygen Inc | G-csf konjugate |
| AU2003210052A1 (en) | 2002-03-20 | 2003-09-29 | Biopolymed Inc. | Preparation of g-csf stoichiometrically conjugated with biocompatible polymers at cystein residue |
| US7666627B2 (en) * | 2002-08-08 | 2010-02-23 | Targetex Kft. | Folded recombinant catalytic fragments of multidomain serine proteases, preparation and uses thereof |
| US7785601B2 (en) | 2002-12-31 | 2010-08-31 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
| US7695723B2 (en) | 2002-12-31 | 2010-04-13 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
| US7220407B2 (en) | 2003-10-27 | 2007-05-22 | Amgen Inc. | G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
| AU2005306894B2 (en) | 2004-11-05 | 2011-11-24 | Northwestern University | Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders |
| RU2007149238A (ru) | 2005-06-01 | 2009-07-20 | Максиджен Холдингз Лтд. (Ky) | Пегилированные полипептиды гксф и способы их получения |
| CL2007002166A1 (es) * | 2006-07-24 | 2008-01-25 | Tetralogic Pharm Corp | Compuestos derivados de heterociclos de nitrogeno, antagonistas de los inhibidores de las proteinas de la apoptosis; sus composiciones farmaceuticas; y uso de dichos compuestos para el tratamiento del cancer. |
| WO2009023566A2 (en) | 2007-08-09 | 2009-02-19 | Genzyme Corporation | Method of treating autoimmune disease with mesenchymal stem cells |
| US8758761B2 (en) | 2007-09-30 | 2014-06-24 | University Of Florida Research Foundation, Inc. | Combination therapies for treating type 1 diabetes |
| US8283372B2 (en) | 2009-07-02 | 2012-10-09 | Tetralogic Pharmaceuticals Corp. | 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic |
| WO2011109556A2 (en) | 2010-03-04 | 2011-09-09 | Pfenex Inc. | Method for producing soluble recombinant interferon protein without denaturing |
| NZ601759A (en) | 2010-03-17 | 2013-07-26 | Biogenerix Gmbh | Method for obtaining biologically active recombinant human g-csf |
| WO2011123570A2 (en) | 2010-04-01 | 2011-10-06 | Pfenex Inc. | Methods for g-csf production in a pseudomonas host cell |
| JP6388581B2 (ja) * | 2012-08-02 | 2018-09-12 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 単量体および多量体分子を生産するための方法およびその使用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4532207A (en) * | 1982-03-19 | 1985-07-30 | G. D. Searle & Co. | Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase |
| DK55685A (da) * | 1985-02-07 | 1986-08-08 | Nordisk Gentofte | Enzym eller enzymkompleks med proteolytisk aktivitet |
| US4530787A (en) * | 1984-03-28 | 1985-07-23 | Cetus Corporation | Controlled oxidation of microbially produced cysteine-containing proteins |
| US5082775A (en) * | 1984-05-11 | 1992-01-21 | Berlex Laboratories, Inc. | Efficient process for isolating insoluble heterologous protein using non-ionic detergents |
| US4948729A (en) * | 1985-03-25 | 1990-08-14 | Cetus Corporation | Production of soluble recombinant proteins |
| US4783415A (en) * | 1985-03-28 | 1988-11-08 | Meiji Seika Kabushiki Kaisha | Gene coding for signal peptides and utilization thereof |
| US5087564A (en) * | 1985-06-20 | 1992-02-11 | Monsanto Company | Release of recombinant peptides from polypeptides using V8 endopeptidase |
| DE3636903A1 (de) * | 1985-12-21 | 1987-07-02 | Hoechst Ag | Fusionsproteine mit eukaryotischem ballastanteil |
| JPH0618781B2 (ja) * | 1986-10-18 | 1994-03-16 | 中外製薬株式会社 | 感染症治療剤 |
| EP0621340A1 (en) * | 1987-03-20 | 1994-10-26 | Creative Biomolecules, Inc. | Product and process for the production and purification of recombinant polypeptides |
| US5013653A (en) * | 1987-03-20 | 1991-05-07 | Creative Biomolecules, Inc. | Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage |
| EP0371041A1 (en) * | 1987-06-24 | 1990-06-06 | Novo Nordisk A/S | A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation |
| DE3835350A1 (de) * | 1988-10-17 | 1990-04-19 | Boehringer Mannheim Gmbh | Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern |
| ZA901719B (en) * | 1989-03-19 | 1991-01-30 | Akzo Nv | Hog cholera virus vaccine and diagnostics |
| US5191063A (en) * | 1989-05-02 | 1993-03-02 | University Of Medicine And Dentistry Of New Jersey | Production of biologically active polypeptides by treatment with an exogenous peptide sequence |
| US5115102A (en) * | 1989-07-21 | 1992-05-19 | Monsanto Company | Variant proteins and polypeptides possessing enhanced affinity for immobilized-metal affinity matrices |
| DE69126434D1 (de) * | 1990-08-20 | 1997-07-10 | Novo Nordisk As | Prozess für die Herstellung von biologisch aktivem IGF-1 durch Verwendung von amino-terminal verlängertem IGF-1 |
-
1991
- 1991-02-21 DE DE4105480A patent/DE4105480A1/de not_active Withdrawn
-
1992
- 1992-01-28 IE IE027692A patent/IE920276A1/en not_active IP Right Cessation
- 1992-02-10 NZ NZ241570A patent/NZ241570A/en not_active IP Right Cessation
- 1992-02-14 AU AU10948/92A patent/AU641081B2/en not_active Ceased
- 1992-02-20 FI FI920742A patent/FI106029B/fi not_active IP Right Cessation
- 1992-02-20 AT AT92102864T patent/ATE144284T1/de not_active IP Right Cessation
- 1992-02-20 ES ES92102864T patent/ES2093122T3/es not_active Expired - Lifetime
- 1992-02-20 ZA ZA921230A patent/ZA921230B/xx unknown
- 1992-02-20 CA CA002061569A patent/CA2061569C/en not_active Expired - Fee Related
- 1992-02-20 MX MX9200709A patent/MX9200709A/es not_active IP Right Cessation
- 1992-02-20 DK DK92102864.3T patent/DK0500108T3/da active
- 1992-02-20 NO NO920671A patent/NO300329B1/no unknown
- 1992-02-20 EP EP92102864A patent/EP0500108B1/de not_active Revoked
- 1992-02-20 JP JP4033257A patent/JP2528232B2/ja not_active Expired - Lifetime
- 1992-02-20 HU HU9200548A patent/HU214881B/hu not_active IP Right Cessation
- 1992-02-20 DE DE59207351T patent/DE59207351D1/de not_active Revoked
- 1992-02-20 IL IL10102492A patent/IL101024A/en not_active IP Right Cessation
- 1992-02-20 CZ CS92499A patent/CZ282744B6/cs not_active IP Right Cessation
- 1992-02-21 KR KR1019920002697A patent/KR950014493B1/ko not_active IP Right Cessation
-
1993
- 1993-10-21 US US08/139,054 patent/US5578710A/en not_active Expired - Lifetime
-
1996
- 1996-10-17 GR GR960402469T patent/GR3021395T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR950014493B1 (ko) | 1995-12-02 |
| ZA921230B (en) | 1992-11-25 |
| CZ282744B6 (cs) | 1997-09-17 |
| EP0500108A3 (en) | 1993-04-07 |
| CS49992A3 (en) | 1992-09-16 |
| IE920276A1 (en) | 1992-08-26 |
| AU1094892A (en) | 1992-08-27 |
| IL101024A (en) | 1996-06-18 |
| MX9200709A (es) | 1992-09-01 |
| NO300329B1 (no) | 1997-05-12 |
| JP2528232B2 (ja) | 1996-08-28 |
| FI920742A (fi) | 1992-08-22 |
| US5578710A (en) | 1996-11-26 |
| CA2061569C (en) | 2000-10-24 |
| FI106029B (fi) | 2000-11-15 |
| HU214881B (hu) | 1998-07-28 |
| DE59207351D1 (de) | 1996-11-21 |
| JPH05244977A (ja) | 1993-09-24 |
| FI920742A0 (fi) | 1992-02-20 |
| HUT68021A (en) | 1995-04-04 |
| NZ241570A (en) | 1994-09-27 |
| ES2093122T3 (es) | 1996-12-16 |
| KR920016464A (ko) | 1992-09-24 |
| AU641081B2 (en) | 1993-09-09 |
| EP0500108A2 (de) | 1992-08-26 |
| NO920671L (no) | 1992-08-24 |
| CA2061569A1 (en) | 1992-08-22 |
| DE4105480A1 (de) | 1992-08-27 |
| NO920671D0 (no) | 1992-02-20 |
| ATE144284T1 (de) | 1996-11-15 |
| GR3021395T3 (en) | 1997-01-31 |
| EP0500108B1 (de) | 1996-10-16 |
| IL101024A0 (en) | 1992-11-15 |
| HU9200548D0 (en) | 1992-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0500108T3 (da) | Forbedret aktivering af rekombinante proteiner | |
| DE69033040T2 (de) | Verfahren zur Herstellung von biologisch aktivem Protein (z.B. TGF) | |
| NO971875L (no) | Cathepsin 02 protease | |
| DE59101580D1 (de) | Trägergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine. | |
| ATE255638T1 (de) | Nukleotidsequenzen und gegen cycloheximid resistente proteine | |
| ES2124247T3 (es) | Conjugado de calcitonina y de polietilenglicol. | |
| DE68907635D1 (de) | Loetmaterial fuer brillengestelle und brillengestelle, bei denen dieses loetmaterial verwendet ist. | |
| TR199901190T2 (xx) | Interferon-(alfa) N�kleik asitlerinin verilmesi ve sentezlenmesi i�in y�ntemler ve bile�imler. | |
| DE59208622D1 (de) | Dentalwerkstoffe auf Basis von (Meth)-Acrylaten | |
| SE9602822D0 (sv) | New receptor | |
| DE68910771T2 (de) | Verfahren zur Herstellung von verbessertem Proteinhydrolysat. | |
| FI893587A (fi) | Menetelmä ei-glykosyloidun rekombinantti-humaani-IL2:n valmistamiseksi sen pelkistyneessä muodossa | |
| DK1040191T3 (da) | RANTES-mutanter og terapeutiske anvendelser heraf | |
| IT8719551A0 (it) | Plasmidi ricombinanti utili perl'espressione in bacillus di proteine eterologhe. | |
| DE59109235D1 (de) | Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung | |
| DE69534738D1 (de) | Leukocyten-aktivierender Faktor | |
| ATE150765T1 (de) | Neue peptide, deren intermediate, verfahren zu deren herstellung, antiallergische agenzien, vasodilatoren und immunoregulatoren | |
| ATE76081T1 (de) | Verfahren zur herstellung von dipeptiden mit nterminalen nichtproteinogenen aminosaeuren. |